Search research articles
Contact Us
Filters
Showing results (31-40 of 91) with videos related to
Page
of 10
Sort By:
Vaccine
|
August 8, 2009
Topical resiquimod promotes priming of CTL to parenteral antigens
Brent A Chang, Jennifer L Cross, Hossain M Najar, et al.
The Journal of Rheumatology. Supplement
|
November 3, 2011
Psychiatric disorders in patients with immune-mediated inflammatory diseases: prevalence, association with disease activity, and overall patient well-being
John R Walker, Lesley A Graff, Jan P Dutz, et al.
Clinical Reviews in Allergy & Immunology
|
December 21, 2007
Pathophysiology of cutaneous lupus erythematosus
Julie H Lin, Jan P Dutz, Richard D Sontheimer, et al.
Diabetes
|
July 30, 2002
Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced
Bronwyn A O'Brien, Yongqian Huang, Xuan Geng, et al.
Vaccine
|
May 4, 2004
Antennapedia transduction sequence promotes anti tumour immunity to epicutaneously administered CTL epitopes
Marie-Paule M Schutze-Redelmeier, Spencer Kong, Marcel B Bally, et al.
Archives of Dermatology
|
March 21, 2007
Treatment of atypical nevi with imiquimod 5% cream
Najwa Somani, Magdalena Martinka, Richard I Crawford, et al.
The American Journal of Medicine
|
April 19, 2016
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Analysis of Triggers and Implications for Improving Prevention
Monica A Miliszewski, Mark G Kirchhof, Sheena Sikora, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 22, 2002
In situ beta cell death promotes priming of diabetogenic CD8 T lymphocytes
Yiqun Zhang, Bronwyn O'Brien, Jacqueline Trudeau, et al.
Journal of the American Academy of Dermatology
|
May 26, 2025
Predictors of drug survival of biologics in hidradenitis suppurativa: A systematic review and meta-analysis
Daniel G Rayner, David Gou, Leonardo Ologundudu, et al.
Journal of the American Academy of Dermatology
|
August 4, 2014
Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine
Mark G Kirchhof, Monica A Miliszewski, Sheena Sikora, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 91) with videos related to
Sort By:
Page
of 10
Vaccine
|
August 8, 2009
Topical resiquimod promotes priming of CTL to parenteral antigens
Brent A Chang, Jennifer L Cross, Hossain M Najar, et al.
The Journal of Rheumatology. Supplement
|
November 3, 2011
Psychiatric disorders in patients with immune-mediated inflammatory diseases: prevalence, association with disease activity, and overall patient well-being
John R Walker, Lesley A Graff, Jan P Dutz, et al.
Clinical Reviews in Allergy & Immunology
|
December 21, 2007
Pathophysiology of cutaneous lupus erythematosus
Julie H Lin, Jan P Dutz, Richard D Sontheimer, et al.
Diabetes
|
July 30, 2002
Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced
Bronwyn A O'Brien, Yongqian Huang, Xuan Geng, et al.
Vaccine
|
May 4, 2004
Antennapedia transduction sequence promotes anti tumour immunity to epicutaneously administered CTL epitopes
Marie-Paule M Schutze-Redelmeier, Spencer Kong, Marcel B Bally, et al.
Archives of Dermatology
|
March 21, 2007
Treatment of atypical nevi with imiquimod 5% cream
Najwa Somani, Magdalena Martinka, Richard I Crawford, et al.
The American Journal of Medicine
|
April 19, 2016
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Analysis of Triggers and Implications for Improving Prevention
Monica A Miliszewski, Mark G Kirchhof, Sheena Sikora, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 22, 2002
In situ beta cell death promotes priming of diabetogenic CD8 T lymphocytes
Yiqun Zhang, Bronwyn O'Brien, Jacqueline Trudeau, et al.
Journal of the American Academy of Dermatology
|
May 26, 2025
Predictors of drug survival of biologics in hidradenitis suppurativa: A systematic review and meta-analysis
Daniel G Rayner, David Gou, Leonardo Ologundudu, et al.
Journal of the American Academy of Dermatology
|
August 4, 2014
Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine
Mark G Kirchhof, Monica A Miliszewski, Sheena Sikora, et al.
Page
of 10